A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis
Clinical trial NCT02460068 · UNKNOWN
Trial details
- NCT number
- NCT02460068
- Sponsor
- Italian Network for Tumor Biotherapy Foundation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-01-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.